These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17941275)

  • 1. Oral corticosteroid-dependent asthma: a 30-year review.
    Randhawa I; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):291-302; quiz 302-3, 370. PubMed ID: 17941275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma.
    Ververeli K; Chipps B
    Ann Allergy Asthma Immunol; 2004 May; 92(5):512-22. PubMed ID: 15191019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for the treatment of chronic corticosteroid-dependent asthma.
    Reid DJ; Segars LW
    Clin Pharm; 1993 Oct; 12(10):762-7. PubMed ID: 8258256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.
    Domingo C; Moreno A; Mirapeix R
    Intern Med J; 2011 Jul; 41(7):525-36. PubMed ID: 21762333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab: a novel therapy for allergic asthma.
    Davis LA
    Ann Pharmacother; 2004; 38(7-8):1236-42. PubMed ID: 15187202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.
    Halpern MT; Schmier JK; Van Kerkhove MD; Watkins M; Kalberg CJ
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients.
    Domingo C; Moreno A; José Amengual M; Montón C; Suárez D; Pomares X
    Curr Med Res Opin; 2011 Jan; 27(1):45-53. PubMed ID: 21083517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study.
    Decco ML; Neeno TA; Hunt LW; O'Connell EJ; Yunginger JW; Sachs MI
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):29-32. PubMed ID: 9988203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a best outcome measurement for patients with asthma?
    Kemp J
    Ann Allergy Asthma Immunol; 2006 Oct; 97(4):432-9. PubMed ID: 17069093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-resistant asthma: evaluation and management.
    Nimmagadda SR; Spahn JD; Leung DY; Szefler SJ
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):345-55; quiz 355-6. PubMed ID: 8933772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data.
    Molimard M; Buhl R; Niven R; Le Gros V; Thielen A; Thirlwell J; Maykut R; Peachey G
    Respir Med; 2010 Sep; 104(9):1381-5. PubMed ID: 20599369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma.
    Nguyen VQ; Ulrik CS
    Allergy Asthma Proc; 2016 Nov; 37(6):125-139. PubMed ID: 27931289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology.
    Leone FT; Fish JE; Szefler SJ; West SL
    Chest; 2003 Dec; 124(6):2329-40. PubMed ID: 14665517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma.
    Slaton RM; Thomas RH; Mbathi JW
    Ann Pharmacother; 2013 Apr; 47(4):578-85. PubMed ID: 23548650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and asthma.
    Kearney DM; Lockey RF
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):769-74; quiz 775-8, 857. PubMed ID: 16802763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-induced hypersensitivity reactions.
    Butani L
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):439-45; quiz 445-6, 502. PubMed ID: 12452199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical considerations of nebulized corticosteroid in children with acute asthmatic exacerbation: A consensus.
    Direkwattanachai C; Aksilp C; Chatchatee P; Jirapongsananuruk O; Kamalaporn H; Kamchaisatian W; Lochindarat S; Ngamtrakulpanit L; Poachanukoon O; Trakultivakorn M; Teeratakulpisarn J; Udomittipong K; Vangveeravong M; Deerojanawong J
    Asian Pac J Allergy Immunol; 2021 Sep; 39(3):168-176. PubMed ID: 30660170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to reduce corticosteroid-related adverse events in asthma.
    Heffler E; Bagnasco D; Canonica GW
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):61-67. PubMed ID: 30407207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A perspective on systemic corticosteroid therapy in severe bronchial asthma in adults.
    Klaustermeyer WB; Choi SH
    Allergy Asthma Proc; 2016 May; 37(3):192-8. PubMed ID: 27178888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.